TEVA revenue breakdown overview

TEVA revenue for the last year amounted to 57.64 B ILS, the most of which — 58.44 B ILS — came from its highest performing source at the moment, Generics, Innovative Medicines and Over-the-counter Products, the year earlier bringing 50.15 B ILS. The greatest contribution to the revenue figure was made by North America — last year it brought TEVA 29.96 B ILS, and the year before that — 25.04 B ILS.